NHS needs national aid to cash in on its data

Read More

Sensyne Welcomes Patient Data Use Endorsement From UK Government

Read More

U.K. sets out digital, data-driven plan to accelerate R&D

Read More

Nimble biotechs become vital partners for large pharma groups

Read More

Sensyne Health marries healthcare with AI

Read More

Prof Lionel Tarassenko and Prof Eric Topol contrast the precision monitoring of jet engines with monitoring systems in patients

Read More

GDm-Health™ patient app-to-clinician software system featured on BBC South Today

Read More

Sensyne Health launches new software product in five NHS Trusts in UK

Read More

AI app for gestational diabetes adopted by NHS

Read More

Sensyne’s gestational diabetes AI app launches on the NHS

Read More

NHS adopts AI app for gestational diabetes

Read More

Drug Hunters and Centaur Chemists: How AI is fundamentally changing the way Big Pharma discovers drugs

Read More

MIDAS SHARE TIPS: If you want healthy profits consider the firm seeking cures using NHS records

Read More

Senior appointment at Lord Drayson's healthcare tech firm

Read More

Sensyne Health appoints Lionel Tarassenko as Non-Executive Director

Read More

Sensyne Health highlighted in BioSpace’s recent survey on Top 5 Trends in the Life Sciences Industry

Read More

Rethink needed over use of automated health records

Read More

Two defensive income funds and one speculative growth portfolio – all worth holding

Read More

Sensyne Health welcomes code on data-driven health and care technologies

Read More

Sensyne Health featured on BBC Radio 4's 'Today' programme (47m:50s)

Read More

NHS set to be offered a ‘fair share’ of data profits

Read More

The NHS needs to cash in on data drive

Read More

Sensyne Health has healthy start to life on the stock market

Read More

Peer holds key to unlock the value of NHS patient data

Read More

Sensyne Health begins trading on AIM (Bloomberg Daybreak: Europe)

Read More

Sensyne Health makes positive debut on AIM

Read More

Sensyne Health makes solid start on AIM debut

Read More

Sensyne Health senses $76m IPO

Read More

NHS ‘owes it to society to make money from patients’ information’

Read More

Lord Drayson’s Sensyne Health raise £60m in float

Read More

Sensyne Health CEO Drayson says IPO will see AI group to profitability

Read More

Former minister Lord Drayson drives AI health trailblazer to £160m listing

Read More

Drayson floats medical AI group Sensyne Health on AIM

Read More

Sensyne Health/AI: doctored data

Read More

Sensyne Health sets AIM IPO price at 175p per share, giving it an initial market cap of £225m

Read More

Sensyne Health signs exclusive licence agreement for a digital health software product, Support-HF

Read More

Lord Drayson: I want to build a world-leading tech company

Read More

Sensyne Health collaborates to improve Support-HF software product

Read More

Biotech entrepreneur Drayson plans to list new AI drug research firm

Read More

Sensyne Health planning to raise £60m via AIM IPO according to founder Paul Drayson

Read More

AI data miner Sensyne Health looks to go public with $77M listing

Read More

Sensyne Health extends its agreement with Oxford University Hospitals

Read More

Mining real world data for drug development insights, Woodford-backed AI firm seeks $77M London IPO

Read More

AI healthtech start-up pressing ahead with IPO

Read More

Medtech and the Internet of Medical Things: How connected medical devices are transforming health care, featuring GDm-Health on page 30.

Read More

If NHS patient data is worth £10 billion, put it on the balance sheet and save lives too

Read More

UK digital health start-up to commercialise products with NHS

Read More

Former UK science minister Lord Drayson explains his plans for Sensyne Health, an Oxford, UK-based AI-focused healthcare technology company

Read More

There is no reason why rich, machine-learning friendly datasets from public services should be free to access for AI companies.

Read More

The unique collaboration between Drayson Health, the University of Oxford and the NHS Foundation Trust cited as the exemplar framework for using NHS data

Read More

Sharing our data could help to fund the NHS — all it needs is for us to say yes

Read More

Women's Healthcare Comes Out Of The Shadows: Femtech Shows The Way To Billion-Dollar Opportunities

Read More

Self-monitoring solution for gestational diabetes shows promise in trials

Read More

Professor David Clifton made Research Director of digital health developer Drayson Health

Read More

Evidence-based patient-to-clinican app to help support increasing burden of gestational diabetes

Read More

The UK cannot compete in the digital age without top universities

Read More

NHS seal of approval for gestational diabetes app

Read More

'Ground-breaking' deal in Oxford sees NHS products commercialised

Read More

Sky's Alex Morgan gets an exclusive look at the tablet tech at John Radcliffe Hospital

Read More

NHS to start prescribing health apps that help manage conditions

Read More

UK digital health start-up to commercialise products with NHS

Read More

Schrödinger Building, Oxford Science Park

Oxford Office

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

+44 (0) 330 058 1845

Contact us

For press enquiries, please contact press@sensynehealth.com